Neurointerventional Device MarketThe global neurointerventional device market, valued at USD 2.6 billion in 2023, is ...

InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of ...